they essentially wreak the drug market. they really didn't have to give esrx that kind of deal in the first place...now they are to blame for the damage...they could have made more money had they negotiated right...stupid management.
who are these boneheads at cnbc to tell me who impresses or who doesn't? and if what they say take down a stock, i might as well buy if i see otherwise.
they say gild's manufacturing cost shows mark up of 279,000 percents...but they fail to report the acquisition cost and development to bring the drug to market...those so call reporters quoted from esrx...the liberal media is just plain deceptive and dishonest.
discount is good...i like to make money...but to do so and also save as many lives as possible, its a privilege...so i don't mind the discounts as long as money keeps rolling in from the drug...moving on from hep c already...
you said, it...high volume, moving higher for days....its call breakout and insider buying confirms things must be moving in the right direction for the company. its one of the things they are waiting for to buy...should be a good year in 2015.
why bother to respond to that dumb post anyways? icpt's drug will be on the market sooner than expected with the fda designation. so just stop wasting time on the nonsense mb trash you read. pay attention to what the company has to report and update instead.
as much as i like this stock, can't complain with this kind of profit. hopefully they succeed with their drugs.
the expenses you are talking about above excludes other compensations...they will be out of cash. you will revisit this post later this year.
as af's article points out, it was a completely wrong move by abbv management, the ceo in particular...discount yes, but not like that...either way, they would not have been able to compete with gild...but giving up 40 percent plus vs., say 30 percent or whatever...esrx doesn't have alternatives...either gild or abbv...
they are expecting the drug to be on the market next year and the sales and marketing prep work has started.
everyone who wants it already own it. all of a sudden the watch is an issue for the stock...its not even out yet. so only negative stuff can move it down...nothing good will move it up...